Summary: https://www.greenstocknews.com GLOBAL HEMP GROUP announced today that it has signed a binding Letter of Intent with Prescient Strategies Group to acquire its Western Sierra Resource Corporation Preferred A Class Share holdings in a private, third party transaction. The acquisition will give GHG control over WSRC, and specifically its strategic water infrastructure assets that will be an integral part of the Company’s Colorado Hemp-Agro Industrial Zone project as originally announced on September 16, 2020. Global Hemp Group Inc. trades on the CSE under the symbol GHG and on the OTC under thes symbol GBHPF). The company is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry the United States. For more information visit www.globalhempgroup.com --- https://www.accesswire.com/624615/Key-Capital-COVID-19-Oral-Pill-Vaccine-Records-90-Reduction-in-Virus-Infectivity-in-Early-Study KEY CAPITAL reported today that current independent laboratory testing of its partnered Immunitor COVID-19 patented oral pill vaccine in an ongoing university study is providing promising early support for safety and efficacy of the vaccine. The preliminary tests conducted by a leading Asian research institute have shown safety and a 90% reduction on virus infectivity in mammalian cells following exposure to the active vaccine. This laboratory testing highlights the vaccine methodology and ability to inactivate and/or prevent viral infection and its potential for oral mucosal administration. Key Capital trades on the OTC MARKETS under the symbol KCPC. For more information on the Company’s visit their website at www.keybiotec.com --- https://www.newsfilecorp.com/release/72247/Nextleaf-Solutions-Granted-Patent-for-CBD-Prodrug-and-Prepares-for-Pharmaceutical-Participation?k=nextleaf Innovative cannabis extractor NextLeaf Solutions announced today that the Canadian Intellectual Property Office has granted the Company a patent for its CBD Prodrug. This patented process to produce CBD-O-Acetate enables the standardization of a more potent analog of CBD through targeted drug delivery. The Company plans to commercialize this intellectual property through IP licensing, and the production of IP protected cannabinoid-based products as legally permitted by Health Canada. Shares of NextLeaf trade on the CSE under the ticker symbol OILS and on the OTC MARKETS under the symbol OILFF. Nextleaf owns 12 issued U.S. patents and 70 issued patents globally for the extraction, purification, and delivery of cannabinoids - representing the 2nd largest patent portfolio among all cannabis companies. For more information visit www.nextleaf.ca --- https://www.globenewswire.com/news-release/2021/01/18/2159922/0/en/CloudMD-Expands-Virtual-Mental-Health-Services-Through-Acquisition-of-Aspiria-Corp-a-Healthcare-Provider-Focused-on-Delivering-Employee-EAP-and-Student-SAP-Assistance-Programs.html CloudMD Software & Services, a telehealth company seeking to revolutionize the delivery of healthcare to its members, today reported that it has signed a binding term sheet to acquire 100% of Aspiria Corporation. Aspiria is an integrated, EAP and Student Assistance Services company that focuses on a comprehensive suite of mental health and wellness solutions for all employer and educational sectors. Aspiria currently serves over 750 organizations, with 1 million employees, students, and their families, in Canada and internationally. Aspiria will now become part of CloudMD’s Enterprise Health Solutions Division and is immediately synergistic with a number of healthcare solutions in the division. Aspiria will complement CloudMD’s other mental health solutions including Snapclarity and HumanaCare to promote effective and efficient clinical best practices in managing mild, moderate and chronic conditions. CloudMD trades on the TSX Venture exchange under the ticker symbol DOC and on the OTC Market under DOCRF. The Company is digitizing delivery of...
